Navigation Links
Scientists win $2 million to study new pathway in development and maintenance of lymphoma
Date:3/30/2012

JUPITER, FL, March 30, 2012 The National Institutes of Health has awarded The Scripps Research Institute $2 million to study the role of a pathway in the development and maintenance of B-cell lymphoma, a type of cancer that begins in immune system and turns normal disease fighting cells into cancers. The disease affects immune cells known as lymphocytes, which are part of our white blood cells.

John Cleveland, PhD, chair of the Department of Cancer Biology on the Scripps Florida campus, will be the principal investigator for the new five-year study.

B-cell lymphomas tend to occur in older patients and in those people whose immune system has been compromised. It is one of the most common blood cancers in the United States and kills about 20,000 Americans each year.

The new project will focus on the role of Myc oncoproteinsthe products of Myc oncogeneswhich are activated in over half of all human tumor types. Myc oncoproteins accelerate the rate of cell growth, which increases the risk of acquiring additional mutations that allow a premalignant cell to develop into a full-blown tumor. In this project, the Cleveland lab will investigate the role of a pathway that controls the destruction of a class of messenger RNAs (mRNAs) that encode proteins that regulate the development and maintenance of tumors.

"This grant allows us to focus on a new pathway that is controlled by Myc that we think is suitable to target for the development of new anti-cancer drugs," said Cleveland, who has led numerous studies shedding light on this oncogene. "We are very hopeful that learning more about this process will open the door for the development of new treatments."

Specifically, the new project aims to define the mechanisms by which Myc controls the expression and function of Tristetraprolin or TTP, a mRNA-binding protein that normally controls the destruction of a subset of important mRNAs. Importantly, Research Associate Robert Rounbehler, PhD, and other colleagues in the Cleveland lab have shown that TTP functions as a tumor suppressor that impairs the development and maintenance of B lymphoma. Their findings indicating that agents that regulate TTP or affect its key mRNA targets hold great promise as anti-cancer agents.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientists identify novel inhibitor of human microRNA
3. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
4. MU scientists go green with gold, distribute environmentally friendly nanoparticles
5. Scientists identify gene that may contribute to improved rice yield
6. Scientists discover why a mothers high-fat diet contributes to obesity in her children
7. MU scientists see how HIV matures into an infection
8. Earth scientists keep an eye on Texas
9. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
10. Scientists identify a molecule that coordinates the movement of cells
11. Scientists Find new migratory patterns for Mediterranean and Western Atlantic bluefin tuna
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists win $2 million to study new pathway in development and maintenance of lymphoma
(Date:9/22/2018)... , ... September 21, 2018 , ... ... (PE) and, if left untreated, can lead to significant morbidity and mortality. VTE ... of cases diagnosed upon autopsy. Further, PE is the leading cause of preventable ...
(Date:9/12/2018)... Minn. (PRWEB) , ... September 11, 2018 , ... ... wall coatings, is proud to introduce the new ChemXP™ line of high performance ... environments. The line was developed to provide Tennant Coatings’ elite certified installers with ...
(Date:9/7/2018)... ... September 06, 2018 , ... Sensors Midwest ... show Sensors Expo & Conference , announces their partnership with Fraunhofer USA ... an IoT Enabled Industrial IoT Certification Program. Taking place on October 17, 2018 ...
Breaking Biology News(10 mins):
(Date:9/1/2018)... , ... August 31, 2018 , ... ... results of the impact of a proprietary biofield energy treated nutraceutical supplement used ... biomarkers for immune function response and blood, as well as, organ-specific inflammation. The ...
(Date:8/29/2018)... ... August 28, 2018 , ... Inc. ... lenses, has been ranked in 1138th place on the 27th annual Inc. 5000, ... The list represents the most successful companies within the American economy’s most dynamic ...
(Date:8/26/2018)... Korea (PRWEB) , ... August 24, 2018 , ... ... paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a ... , According to the paper, the symptoms of mice having severe atopic ...
(Date:8/17/2018)... ... August 16, 2018 , ... The opening of the new Titusville ... Technical Services in 2016. Chemko had a well established local presence, servicing the Space ... on projects such as the ongoing work at the Mobile Launch Platform (MLP) in ...
Breaking Biology Technology: